PIM_Glyxambi

{
  "compose" : {
    "exclude" : [ ],
    "include" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "extension" : [ {
        "extension" : [ {
          "valueString" : "concept",
          "url" : "path"
        }, {
          "url" : "count",
          "valueInteger" : 17
        } ],
        "url" : "http://health-samurai.io/extensions/excised-data"
      } ]
    } ]
  },
  "date" : "2023-10-19T01:11:23-04:00",
  "meta" : {
    "versionId" : "6",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
  },
  "publisher" : "Optum Steward",
  "jurisdiction" : [ {
    "coding" : [ {
      "system" : "urn:iso:std:iso:3166",
      "code" : "US"
    } ]
  } ],
  "purpose" : "(Clinical Focus: Medications containing Glyxambi in different strengths),(Data Element Scope: DRUG_CLASS_MEMBERS: PHARMACOLOGIC),(Inclusion Criteria: includes both brand and generic of Empagliflozin/Linagliptin combination),(Exclusion Criteria: Single ingredient drugs of Empagliflozin and Linagliptin)",
  "name" : "PIM_Glyxambi",
  "resourceType" : "ValueSet",
  "expansion" : {
    "contains" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1151131",
      "display" : "Oral Product",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1151133",
      "display" : "Pill",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1598392",
      "display" : "empagliflozin / linagliptin",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1602106",
      "display" : "empagliflozin / linagliptin Oral Product",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1602107",
      "display" : "empagliflozin / linagliptin Pill",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1602108",
      "display" : "empagliflozin / linagliptin Oral Tablet",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1602109",
      "display" : "empagliflozin 10 MG / linagliptin 5 MG Oral Tablet",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1602110",
      "display" : "Glyxambi",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1602111",
      "display" : "empagliflozin 10 MG / linagliptin 5 MG [Glyxambi]",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1602112",
      "display" : "empagliflozin / linagliptin Oral Tablet [Glyxambi]",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1602113",
      "display" : "Glyxambi Oral Product",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1602114",
      "display" : "Glyxambi Pill",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1602115",
      "display" : "empagliflozin 10 MG / linagliptin 5 MG Oral Tablet [Glyxambi]",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1602118",
      "display" : "empagliflozin 25 MG / linagliptin 5 MG Oral Tablet",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1602119",
      "display" : "empagliflozin 25 MG / linagliptin 5 MG [Glyxambi]",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1602120",
      "display" : "empagliflozin 25 MG / linagliptin 5 MG Oral Tablet [Glyxambi]",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "317541",
      "display" : "Oral Tablet",
      "version" : "11042024"
    } ],
    "total" : 17,
    "identifier" : "urn:uuid:e4adcd8b-f9e9-4ce5-bd5f-0c39f3bf521e",
    "timestamp" : "2024-12-10T05:46:32-05:00"
  },
  "title" : "PIM_Glyxambi",
  "extension" : [ {
    "valueContactDetail" : {
      "name" : "Optum Author"
    },
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
  }, {
    "valueDate" : "2023-10-19",
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
  }, {
    "valueDate" : "2023-10-19",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
  }, {
    "url" : "http://health-samurai.io/extensions/source",
    "valueCode" : "db"
  } ],
  "status" : "active",
  "id" : "abb90e3f-aae7-40b3-b9f8-7d8a39d660e4",
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.691",
  "identifier" : [ {
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113762.1.4.1078.691"
  } ],
  "version" : "20231019"
}